Abstract
Background: Pulmonary lymphangiomyomatosis is relatively rare disease and it is a systemic disease with an unknown etiology. The abnormal proliferation of smooth muscle leads to the obstruction of bronchi, lymphatic vessels and small blood vessels. At present, there are not many clinical reports on the treatment of LAM thoracoscopic surgery. So this article reports a case of LAM in a middle-aged woman and reviews of the relevant literature.
Highlights
LAM mostly occurs in women and the etiological mechanism is currently unclear [1]
We found that very few patients with LAM have extrapulmonary manifestations, which are diagnosed under pathological biopsy of extrapulmonary tissues
Thoracoscopic surgery for LAM with pulmonary bullae can effectively reduce the recurrence rate of pneumothorax, not all patients with LAM are suitable for Video Assisted Thoracoscopic Surgery (VATS) treatment
Summary
Surgical treatment of LAM under thoracoscopy is the most recent direct treatment to relieve pneumothorax. The recurrence rate of pneumothorax after thoracoscopic surgery is still high, it has been obviously reduced pneumothorax recurrence rate compared with traditional medical conservative treatment. The authors have no ethical conflicts to disclose
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
